NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 119 filers reported holding NURIX THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $250,946 | -23.2% | 31,927 | -2.4% | 0.00% | 0.0% |
| Q2 2023 | $326,733 | +104287.5% | 32,706 | -7.1% | 0.00% | 0.0% |
| Q1 2023 | $313 | -6.3% | 35,215 | +15.8% | 0.00% | 0.0% |
| Q4 2022 | $334 | -99.9% | 30,403 | +1.3% | 0.00% | -50.0% |
| Q3 2022 | $391,000 | +3.2% | 30,006 | +0.4% | 0.00% | 0.0% |
| Q2 2022 | $379,000 | -7.1% | 29,897 | +2.7% | 0.00% | 0.0% |
| Q1 2022 | $408,000 | -51.4% | 29,124 | +0.4% | 0.00% | -50.0% |
| Q4 2021 | $840,000 | -3.3% | 29,018 | +0.1% | 0.00% | -20.0% |
| Q3 2021 | $869,000 | – | 29,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 15,823 | $163,293 | 0.00% |